Personalized mRNA cancer vaccines are showing early success in clinical trials, fueling optimism in the fight against cancer.

The FDA's approval of an mRNA flu shot presents a new, long-awaited option—and raises big questions about the future of flu ...

A year to the day after the Trump administration slashed $500 million in funding from mRNA-based programs, the FDA approved ...

St. Louis researchers played a vital role in clinical trials for a newly approved tool designed to protect families ahead of ...

The announcement from Merck & Co. and Moderna last month that their mRNA cancer vaccine had successfully lengthened patient ...

The U.S. Food and Drug Administration has approved a new seasonal flu vaccine from Moderna that uses mRNA technology, the drugmaker announced.

A new kind of flu vaccine moved a step closer to the U.S. market Thursday as federal health advisers recommended approval of the first made with the same mRNA technology that was key to ending the ...

Since 1965, messenger RNA (mRNA) vaccines have been studied for cancer treatment, but it was the technological advances in vaccines during the COVID pandemic that helped accelerate research. Currently ...

The flu might be a relatively common illness, but it’s nothing to mess around with. The Centers for Disease Control and Prevention (CDC) estimates that in a typical year, the flu kills tens of ...

Add Yahoo as a preferred source to see more of our stories on Google. Health and Human Services Secretary Robert F. Kennedy Jr. revealed his agency will be cutting funding to mRNA development, calling ...

If you think last week's decision by the federal government to halt $500 million in funding for vaccine development projects that use mRNA technology will only affect COVID vaccines, think again.